Zepbound also became the first prescription medication approved by the FDA to treat moderate-to-severe obstructive sleep apnea in adults with obesity, expanding its clinical use beyond weight management alone
Participants were eligible if we had the following data available at the start of treatment (day 0) and at the follow-up after one year (365 14 days): Before treatment initiation: sex, age (years), body weight (kg), waist circumference (cm), height (cm), body mass index (BMI), systolic and diastolic blood pressure, heart rate, and Edmonton Obesity Staging System (EOSS) score
It is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
In other approaches, Bayesian statistics were applied to overcoming variability caused by the small count in a cell of the two-by-two table (26)
Tirzepatide is a single novel molecule that activates the bodys receptors for GIP and GLP-1, which are natural incretin hormones